Connect with us

Technology

Analytical Standards Market to Grow by USD 657.8 Million (2024-2028) with Rapid Growth in the Life Science Industry Boosting the Market, Report on AI Impact on Market Trends – Technavio

Published

on

NEW YORK, Feb. 6, 2025 /PRNewswire/ — Report on how AI is redefining market landscape – The global analytical standards market size is estimated to grow by USD 657.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  6.78%  during the forecast period. Rapid growth in life science industry is driving market growth, with a trend towards increasing adoption of custom standards. However, limited shelf life of analytical standards  poses a challenge. Key market players include AccuStandard Inc., Agilent Technologies, Inc., Cayman Chemical, Chiron AS, GFS Chemicals, Inc., LGC Limited, Mallinckrodt, Merck KGaA, PerkinElmer, Inc., Restek Corporation, Ricca Chemical Company, SPEX CertiPrep, The United States Pharmacopeial Convention, Thermo Fisher Scientific Inc., Waters Corporation

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF

Analytical Standards Market Scope

Report Coverage

Details

Base year

2023

Historic period

2017 – 2021

Forecast period

2024-2028

Growth momentum & CAGR

Accelerate at a CAGR of 6.78%

Market growth 2024-2028

USD 657.8 million

Market structure

Fragmented

YoY growth 2022-2023 (%)

6.23

Regional analysis

North America, Europe, APAC, South America, and Middle East and Africa

Performing market contribution

North America at 46%

Key countries

US, Germany, China, UK, and India

Key companies profiled

AccuStandard Inc., Agilent Technologies, Inc., Cayman Chemical, Chiron AS, GFS Chemicals, Inc., LGC Limited, Mallinckrodt, Merck KGaA, PerkinElmer, Inc., Restek Corporation, Ricca Chemical Company, SPEX CertiPrep, The United States Pharmacopeial Convention, Thermo Fisher Scientific Inc., Waters Corporation

Market Driver

The Analytical Standards Market is experiencing significant growth due to increasing trends in proteomics and metabolomics, food safety, and quality control. This includes food testing, chromatography, mass spectrometry, and spectroscopy. These techniques are essential for identifying respiratory infections, diseases like cancer, and analyzing metabolites in food products and cell metabolites. Environmental concerns are also driving market growth, with a focus on monitoring sulfur dioxides, carbon dioxide, and air quality. Industries like power plants, renewable fuels, and public transport are key customers. In healthcare, there’s a growing need for analytical standards in infectious diseases, such as influenza, malaria, HIV, and tuberculosis. Genomic techniques, biomarkers, and biologic drugs are also major areas of interest. The market caters to various industries including pharmaceutical, biopharmaceutical, and life sciences. Businesses use analytical standards for stability testing, dissolution testing, bioanalytical testing, raw material testing, clinical trials, and accreditations like ISO standards. Major players in the market include Thermo Fisher Scientific, CD Bioparticles, and FDA. Techniques like titrimetry, thermo Fisher Scientific’s liquid chromatography, and gas chromatography are widely used. Other applications include petrochemistry standards, veterinary drug standards, and pesticides. Business strategies and business segments continue to evolve, focusing on cancer, chronic diseases, and custom synthesis. 

Analytical standards vendors have honed their skills in custom synthesis through various reagent synthesis methods. They maintain inventories of custom synthetic products, ensuring prompt backorders. Seamless scale-up options are a priority for these manufacturers, enabling transportation of custom synthetic materials to large-scale manufacturing facilities and GMP facilities. AccuStandard is one such company specializing in high-purity chemical synthesis for reference standards. Custom synthesis ranges from milligrams to kilograms, with a focus on producing organic pollutants and their metabolites for the community. 

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

 Market Challenges

•         The Analytical Standards Market faces various challenges in sectors like Proteomics and Metabolomics, Food safety, and Quality control in Food testing. Chromatography, Mass spectrometry, and Spectroscopy are crucial analytical techniques used in identifying Respiratory infections, Diseases like Cancer, and environmental issues such as Sulfur dioxides and Carbon dioxide. Industries like Power plants, Renewable fuels, and Public transport impact Air quality, necessitating stringent Environmental standards. In Life sciences, Genomic techniques, Bioanalytical testing, and Stability testing are essential for Drug discovery, Clinical trials, and Accreditations like ISO standards. Businesses in Pharmaceuticals, Biopharmaceuticals, and Healthcare infrastructure deal with challenges like Patent protection, Business strategies, and Segments like Spectroscopy, Calibration standards, and Physical property testing. Veterinary drugs, Petrochemicals, and Pharmaceuticals require specific standards for Titrimetry, Thermo Fisher Scientific, Liquid chromatography, and Gas chromatography. Additionally, Pesticides, Biomarkers, and Biologic drugs face challenges in Drug molecules, Diseases like Cancers and Chronic diseases, and Custom synthesis. Companies like CD Bioparticles and FDA play a vital role in ensuring regulatory compliance.

•         In the analytical industry, maintaining the stability and accuracy of analytical standards over their limited shelf life is a significant challenge. These reference materials, essential for calibrating instruments and validating methods, can undergo chemical reactions, leading to changes in their composition and properties. Exposure to contaminants, such as air, moisture, or other substances, can cause degradation and alteration. Physical changes, like crystallization, aggregation, or evaporation, can also impact their accuracy. Incorrect storage conditions, including high temperatures or humidity, can expedite the degradation process. Proper handling, storage, and regular replacement are crucial to ensure the reliability and consistency of analytical results.

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview 

This analytical standards market report extensively covers market segmentation by  

TypeChromatographySpectroscopyTitrimetryPhysical Properties TestingApplicationFood And BeveragesPharmaceuticals And Life SciencesEnvironmentalOthersGeographyNorth AmericaEuropeAPACSouth AmericaMiddle East And AfricaMethodologyBioanalytical TestingStability TestingRaw Material TestingDissolution TestingOthers

1.1 Chromatography-  The chromatography segment is projected to dominate the global analytical standards market due to its effectiveness in identifying and separating impurities in complex samples. Chromatography’s popularity is driven by the availability of various types, including liquid and gas chromatography, and the ease of use with instruments like mass spectrometers. This technology’s high performance and interoperability with other analytical tools reduce manpower requirements and overall costs, making it an attractive choice for industries. The market’s growth is further fueled by the increasing demand for accurate and efficient analytical methods across various sectors.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

The Analytical Standards Market encompasses a wide range of applications, including Proteomics and Metabolomics for life sciences research, Food safety and Quality control for ensuring the safety and authenticity of food products, and Food testing for regulatory compliance. Technologies such as Chromatography, Mass spectrometry, and Spectroscopy play a crucial role in the analysis of various samples. The market also caters to diverse industries like Respiratory infections and diseases, Accreditations, and ISO standards for ensuring quality and consistency. Calibration standards are essential for maintaining accuracy in analytical instruments, while Titration and Titrimetry are used for quantitative analysis. The market serves various sectors such as Pharmaceutical, Veterinary drug development, Petrochemical, and Cancers and Chronic diseases research. Companies like Thermo Fisher Scientific, CD Bioparticles, and the FDA contribute significantly to the market with their innovative solutions and regulatory compliance.

Market Research Overview

The Analytical Standards Market encompasses various industries, including Proteomics and Metabolomics, where standards play a crucial role in ensuring accuracy and consistency in the analysis of complex biological systems. In Food safety and Quality control, analytical standards are essential for Food testing and ensuring compliance with regulations. Chromatography, Mass spectrometry, and Spectroscopy are key analytical techniques used to identify and quantify various compounds in various matrices. Environmental degradation, Air quality, and Power plants are significant applications of analytical standards in monitoring Sulfur dioxides, Carbon dioxide, and other pollutants. In the Life sciences industry, analytical standards are used for Crop yields, Weather patterns, and Greenhouse effect studies, as well as for analyzing Cell metabolites, Genomics data, and Drug molecules. The Pharmaceutical market, including Biopharmaceutical and Innovator drugs, relies on analytical standards for Stability testing, Dissolution testing, Bioanalytical testing, Raw material testing, and Clinical trials. Accreditations and ISO standards ensure the quality and reliability of analytical standards in various industries, including Veterinary drug, Petrochemical, Pharmaceutical, and Industrialization. Analytical standards are also crucial in the Healthcare industry, particularly in the diagnosis and treatment of various diseases, such as Respiratory infections, Respiratory diseases, Allergic reactions, Cancer, Infectious diseases like Influenza, Malaria, HIV, and Tuberculosis. Genomic techniques, Titrimetry, and other analytical techniques are used to identify biomarkers and develop Biologic drugs through Drug discovery and Custom synthesis processes. Pesticides and Business strategies are other significant applications of analytical standards. The market is segmented into various industries, including Food & beverages, Veterinary drug standards, and Environmental standards. The market is expected to grow due to the increasing demand for accurate and reliable analytical data in various industries.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

TypeChromatographySpectroscopyTitrimetryPhysical Properties TestingApplicationFood And BeveragesPharmaceuticals And Life SciencesEnvironmentalOthersGeographyNorth AmericaEuropeAPACSouth AmericaMiddle East And AfricaMethodologyBioanalytical TestingStability TestingRaw Material TestingDissolution TestingOthers

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/analytical-standards-market-to-grow-by-usd-657-8-million-2024-2028-with-rapid-growth-in-the-life-science-industry-boosting-the-market-report-on-ai-impact-on-market-trends—technavio-302368543.html

SOURCE Technavio

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

11:11 Systems Announces Strategic Partnership with Cato Networks to Deliver SASE Solution for Distributed Enterprises

Published

on

By

New Managed Secure Access Service Edge (SASE) solution combines SD-WAN, cloud-native networking and security capabilities with 11:11’s connectivity, cyber resilience and cloud expertise

SYDNEY, July 22, 2026 /PRNewswire/ — 11:11 Systems, a leading managed infrastructure solutions provider, today announced the global availability of its 11:11 Managed Secure Access Service Edge (SASE) solution and a new strategic partnership with Cato Networks.

11:11 Managed SASE is a fully managed secure connectivity solution leveraging Cato Networks AI-native network security platform. This solution brings together intelligent SD-WAN, cloud-delivered security and global connectivity into a single offering. It enables organisations to simplify and secure access across branch offices, data centres, users and cloud environments, reducing complexity without sacrificing performance or control.

Built on the Cato Networks cloud-native SASE platform, 11:11 Managed SASE combines zero trust network access (ZTNA), firewall as a service (FWaaS), secure web gateway (SWG), cloud access security broker (CASB), advanced threat protection and centralised visibility into a unified managed experience. 11:11 also delivers 24x7x365 monitoring and support, incident management integration and operational accountability to help customers limit vendor sprawl, increase agility and free internal teams to focus on higher-value priorities.

The offering is backed by 11:11’s broader networking, cloud and cyber resilience capabilities. Through its global backbone, carrier-agnostic connectivity options and integrated portfolio spanning cloud, backup, disaster recovery and security services, 11:11 gives customers a practical path to modernise network and security architecture while strengthening resilience across the business.

“Enterprises are under pressure to support users, applications and locations that are more distributed than ever, while limiting complexity and improving security,” said Justin Giardina, CTO, 11:11 Systems. “Our Managed SASE solution provides customers with a unified approach to modernising networking and security, along with the visibility, support and flexibility they need to thrive in a rapidly changing environment.”

According to Karl Soderlund, global channel chief, Cato Networks, “As enterprises move beyond fragmented legacy networking and security stacks, they need a simpler way to gain visibility, context and control across hybrid work environments and reduce the operational burden on IT. Through our partnership, we can address these challenges head on and deliver end-to-end visibility and protection in a single service built for the reality of modern work.”

The joint offering is well suited for distributed enterprises, multi-site organisations, hybrid workforce initiatives, SD-WAN refreshes, security modernisation efforts and businesses with limited IT resources. 11:11 meets customers where they are by supporting existing environments, simplifying multi-vendor operations and serving as a single provider accountable for network, security, cloud and data integration.

This partnership expands 11:11’s Network as a Service portfolio and follows Forrester’s inclusion of 11:11 Systems in its report, “The Secure Access Service Edge Services Landscape, Q1 2026.”

About 11:11 Systems

11:11 Systems is a managed infrastructure solutions provider that empowers customers to modernise, protect and manage mission-critical applications and data, leveraging 11:11’s resilient cloud platform. Learn more at www.1111Systems.com and follow 11:11 on LinkedIn.

View original content:https://www.prnewswire.com/apac/news-releases/1111-systems-announces-strategic-partnership-with-cato-networks-to-deliver-sase-solution-for-distributed-enterprises-302830322.html

SOURCE 11:11 Systems

Continue Reading

Technology

Crowell & Moring Expands Financial Services Group with Former UBS Bank USA General Counsel Cristina Diaz

Published

on

By

NEW YORK, July 21, 2026 /PRNewswire/ — Crowell & Moring has added Cristina Diaz, former executive director and general counsel of UBS Bank USA, and most recently head of legal for UBS’s U.S. Remediation Management Office, to the firm’s Financial Services Group as senior counsel in New York. Diaz brings more than two decades of in-house counsel and law firm experience in bank regulation, compliance, and risk management.

At Crowell, Diaz will counsel banks, fintechs, and digital assets companies on a broad range of bank regulatory matters, including charters and licensing, permissible activities, capital requirements, regulatory enforcement, M&A, and corporate governance. She will also counsel clients navigating the intersection of traditional banking and emerging financial services, including digital assets companies seeking to acquire or establish national banks, and banks exploring partnerships with fintechs and digital assets firms.

At UBS, Diaz advised on the firm’s most pressing regulatory matters, including most recently UBS Bank USA’s charter conversion from a Utah industrial bank to an OCC national bank and key compliance remediations. This work gave Diaz extensive experience navigating relationships with state and federal financial regulators. Earlier in her career, Diaz spent eight years at Davis Polk & Wardwell advising U.S. and foreign banks on bank regulatory matters, M&A, and capital markets transactions.

“Cristina is a highly experienced, solution-oriented attorney who brings deep knowledge in the bank regulatory space. She will be an enormous asset to the firm’s growing regulatory and transactional offerings to banks, digital assets businesses, and fintechs,” said Carlton Greene, Co-Chair of Crowell’s Financial Services Group.

“I am delighted to join Crowell & Moring and integrate my bank regulatory experience with the firm’s nationally-recognized digital assets practice. As traditional banking and emerging financial technologies continue to evolve, clients need actionable and sophisticated legal counsel. Crowell offers the collaborative platform to help institutions successfully execute their growth and compliance strategies,” said Diaz.

Diaz received her J.D. from New York University School of Law, where she was a member of the New York University Law Review, and received her B.A., summa cum laude, from New York University. She is fluent in Spanish.

About Crowell & Moring LLP
Crowell & Moring is an international law firm with operations in the United States, Europe, and MENA. Drawing on significant government, business, industry, and legal experience, the firm helps clients capitalize on opportunities and provides creative solutions to complex regulatory and policy, litigation, transactional, and intellectual property issues. The firm is consistently recognized for its commitment to pro bono service, as well as its comprehensive programs and initiatives to advance the professional and personal development of all members of the Crowell community.

Media Contact:
Email: prteam@crowell.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/crowell–moring-expands-financial-services-group-with-former-ubs-bank-usa-general-counsel-cristina-diaz-302831280.html

SOURCE Crowell & Moring LLP

Continue Reading

Technology

Quantinuum and SoftBank Corp. Publish Joint White Paper on Scaling Practical Quantum Computing Use Cases Toward the Fault-Tolerant Era

Published

on

By

The companies have published a joint white paper mapping commercially relevant quantum computing use cases in quantum chemistry and graph analytics to Quantinuum’s hardware roadmap.The paper provides a framework for assessing how advances in quantum hardware and algorithms, could affect when practical industrial applications become feasible.SoftBank Corp. and Quantinuum will use the roadmap to inform their exploration of future quantum AI data center services and related business models.

TOKYO and BROOMFIELD, Colo., July 22, 2026 /PRNewswire/ — Quantinuum (NASDAQ: QNT) and SoftBank Corp. (“SoftBank”) today announced the publication of “Quantum Computing Frontiers,” a joint white paper that maps two commercially-relevant quantum computing application areas against Quantinuum’s hardware roadmap. The analysis examines how advances in quantum hardware and algorithms could affect when these applications become practical for industrial use.

The paper focuses on two representative application domains that SoftBank is actively using Quantinuum’s systems to research: quantum chemistry for new materials discovery and energy research, and topological data analysis for large-scale graph analytics, including for telecommunications fraud detection. The authors anchor their assessment of the scalability of these two application areas against Quantinuum’s published hardware roadmap, examining how projected advances in hardware capabilities and algorithms may enable the commercial readiness of future industrial applications.

Building on this use-case roadmap, the paper also examines how quantum computing, AI, and high-performance computing could be integrated into future computing infrastructure. It considers how progress across successive hardware generations could inform future quantum AI data center services and related business models, a key focus of the Quantinuum and SoftBank partnership announced last year.

“The key takeaway of this study is that organizations do not need to wait for large-scale, fault-tolerant systems to explore where quantum computing can begin creating value,” said Duncan Jones, General Manager, Applications Group at Quantinuum. “By using today’s systems to develop, benchmark and refine applications in areas such as quantum chemistry and graph analytics, enterprises can build the technical and operational readiness needed for the next era of quantum-enabled computing.”

“The question is no longer whether quantum computing may deliver value, but rather which problem classes become executable at which stage of hardware maturity,” said Ryuji Wakikawa, Senior Vice President & CTO at SoftBank Corp. “However, we believe progress in hardware must be complemented by equally strong developments in quantum algorithms and the integration of quantum systems with AI and high-performance computing.”

The white paper discusses illustrative scenarios describing how representative applications, technology maturity, and potential market opportunities may evolve over time under stated assumptions. The analysis provided in the paper is intended to provide a conceptual framework for understanding potential market evolution and does not represent financial guidance or forecasts. These analyses are intended to support discussion of future technology development and should not be interpreted as commitments regarding commercialization, infrastructure investment, products, services, or financial performance.

The full white paper is available to download on the SoftBank and Quantinuum websites.

About SoftBank Corp.

Guided by the SoftBank Group’s corporate philosophy, “Information Revolution – Happiness for everyone,” SoftBank Corp. (TOKYO: 9434) operates telecommunications and IT businesses in Japan and globally. Building on its strong business foundation, SoftBank Corp. is aiming to activate the potential of AI across its businesses and drive implementation in line with its “Activate AI for Society” growth strategy. While further growing its telecom business, SoftBank is expanding its AI computing infrastructure and AI and Cloud service businesses with the aim of becoming a provider of Next-generation Social Infrastructure. To learn more, please visit https://www.softbank.jp/en/corp/

About Quantinuum

Quantinuum (NASDAQ: QNT) is a leading quantum computing company offering a full-stack platform designed to make quantum computing deployable in real-world environments. The company has commercially deployed multiple generations of quantum systems built on the well-established QCCD architecture, which it has implemented with novel designs and capabilities to achieve the industry’s highest accuracy levels based on average two-qubit gate fidelity.[1] Quantinuum has active engagements with market leaders across pharmaceuticals, material science, financial services, and government and industrial markets. The company has a global workforce of approximately 700 employees, including top scientists and researchers. Over 70% of its technology team holds PhDs or Master’s degrees. Quantinuum’s headquarters is in Broomfield, Colorado, with additional facilities across the United States, United Kingdom, Germany, Japan, Qatar, and Singapore.

For more information, please visit www.quantinuum.com.

Cautionary Statement Concerning Forward-Looking Statements

This press release contains certain statements that may be deemed “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include all statements that are not historical facts. The words “anticipate,” “assume,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “future,” “will,” “seek,” “foreseeable,” the negative version of these words, or similar terms and phrases are intended to identify forward-looking statements. Such statements are based on certain assumptions and assessments made by our management in light of their experience and their perception of historical trends, current economic and industry conditions, expected future developments and other factors they believe to be appropriate. The forward-looking statements included in this release are also subject to a number of material risks and uncertainties, including but not limited to economic, competitive, governmental, and technological factors affecting our operations, markets, products, services and prices. New factors emerge from time to time, and it is not possible for Quantinuum to predict all such factors. Any forward-looking statement speaks only as of the date on which it is made, and, except as required by law, Quantinuum does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

 

[1] As of December 31, 2025.

SOURCE Quantinuum

Continue Reading

Trending